Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System

Let’s talk.

Whether you’re a clinician, researcher, investor, or partner — we’d love to hear from you.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

This device is CE-marked and commercially available in the European Economic Area. In the United States, the device is investigational and limited by federal law to investigational use only. It has not been cleared or approved by the U.S. Food and Drug Administration.